Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boulder/denver blog main
boulder/denver top stories
clinical trials
2
×
detroit blog main
detroit top stories
fda
2
×
indiana blog main
indiana top stories
life sciences
national
2
×
national blog main
national top stories
new york blog main
new york top stories
novartis
2
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
akouos
alder biopharmaceuticals
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amgen
amunix
anirvan ghosh
astrazeneca
biogen
What
medicines
2
×
acquisitions
amgen
announced
approval
bio
candidates
ceo
class
collabs
covid
daniel
deal
developed
drug
fda
gets
gilead
gilead’s
head
help
introduce
ipo
migraine
month
new
nod
o’day
pain
plans
preventive
roundup
sciences
starts
transformative
won
years
Language
unset
Current search:
national
×
novartis
×
fda
×
medicines
×
" clinical trials "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
6 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines